Phase 2 Study of 2 Modalities of Pomalidomide (CC4047) Plus Low-Dose Dexamethasone as Therapy for Relapsed Multiple Myeloma. IFM 2009-02
2010; Elsevier BV; Volume: 116; Issue: 21 Linguagem: Inglês
10.1182/blood.v116.21.859.859
ISSN1528-0020
AutoresXavier Leleu, Michel Attal, Philippe Moreau, Alain Duhamel, Jean Paul Fermand, Mauricette Michalet, Catherine Traullé, Gérald Marit, Murielle Roussel, Brigitte Kolb, Bertrand Arnulf, Laurent Garderet, Claire Mathiot, Margaret Macro, Marie Odile Petillon, Brigitte Pegourié, Anne Marie Stoppa, Sabine Brechiniac, Bruno Royer, Lotfi Benboubker, Denis Caillot, Martine Escoffre‐Barbe, Cyrille Hulin, Jean‐Luc Harousseau, Hervé Avet‐Loiseau, Thierry Façon,
Tópico(s)HIV/AIDS drug development and treatment
Referência(s)